Feng-Hsiu Su

Merck & Co., Inc., Rahway, NJ, USA (United States) — United States

Medicine · Health Sciences

7h-index180citations15works17.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pediatric Urology and Nephrology Studies(5), Urinary Tract Infections Management(5), Chronic Obstructive Pulmonary Disease (COPD) Research(4), Health and Wellbeing Research(4), Antibiotics Pharmacokinetics and Efficacy(3)

Publications15 total

Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial
The Lancet HIV·2024· 17 cited
Subgroup analysis of phase 2 study of ceftolozane/tazobactam in neonates and young infants with pyelonephritis
Microbiology Spectrum·2023· 3 citedOpen Access
Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for <i>Clostridioides difficile</i> Infection (MODIFY III)
Journal of the Pediatric Infectious Diseases Society·2023· 12 citedOpen Access
Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem From a Phase 2, Randomized Clinical Trial in Pediatric Participants With Complicated Intra-abdominal Infection
The Pediatric Infectious Disease Journal·2023· 18 citedOpen Access
Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Clinical Trial
The Pediatric Infectious Disease Journal·2023· 25 citedOpen Access
1143. Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonatal and Pediatric Participants With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized, Clinical Trial
Open Forum Infectious Diseases·2021· 1 citedOpen Access
1154. Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-abdominal Infection: A Phase 2, Randomized Clinical Trial
Open Forum Infectious Diseases·2021· 3 citedOpen Access
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study
Liver International·2019· 11 cited
Efficacy and Safety of Elbasvir/Grazoprevir for 8 or 12 Weeks in Participants with Hepatitis C Virus Genotype 4 Infection
HAL (Le Centre pour la Communication Scientifique Directe)·2018· 2 cited
A qualitative study of patients' goals and expectations for self-management of COPD
Primary Care Respiratory Journal·2012· 67 citedOpen Access
Six Month Results Of A Behavioral Self-Management Effectiveness Trial To Enhance Lifestyle Physical Activity Among Patients With COPD
2012· 1 cited
Association of Hindfoot Ligament Tears and Osteochondral Lesions
Foot & Ankle International·2011· 4 cited
Urban-rural differences in health status among patients with chronic obstructive pulmonary disease (COPD)
2011
Assessment of self-management needs among patients with COPD
2011
Geographic disparity in COPD hospitalization rates among the Texas population
Respiratory Medicine·2011· 16 citedOpen Access

Frequent Co-authors

Sejong Bae(5), Bradford E. Jackson(5), David Coultas(5), Matthew G. Johnson(5), Julia Lonchar(5), Jennifer A. Huntington(5), Christopher Bruno(5), Sumihiro Suzuki(5), Karan P. Singh(4), Myra W. Popejoy(4), Mekki Bensaci(4), Elizabeth G. Rhee(4), Emmanuel Roilides(3), John S. Bradley(3), Kaming Lo(3), Kathryn Wortz(2), Angela Cade(2), Negar Ashouri(2), Carisa De Anda(2), Carl-Christian A. Jackson(2)